We develop, manufacture and market a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region and Europe. We are also a leading licensing partner in the MENA region. Our operations span over 50 countries and are conducted through three business segments.
Our Branded business develops, manufactures and markets branded generics and a portfolio of in-licensed products, many of which are still patent-protected. We have strong market positions across the MENA region, supported by our broad product portfolio, large sales and marketing team and high-quality manufacturing facilities.
Our Generics business sells non-injectable generic products in the US market. We have a large portfolio and pipeline of highly differentiated products, focusing on niche segments of the maket. We manufacture our non-injectable products at our US FDA-approved facilities in the US, Jordan and Saudi Arabia.